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The ultimate goal of our research is the regulation of cellular 
functions using designed peptides and proteins. Current research 
subjects include 1) development of novel intracellular delivery 
systems aiming at elucidation and control of cellular functions 
using designed membrane-permeable peptide vectors, 2) elucida­
tion of the DNA binding modes of zinc finger proteins and TALEs, 
and design of artificial transcription factors with various DNA 
binding specificities, 3) elucidation and control of membrane 
 curvature, and 4) design of 
stimulation-responsible artifi­
cial peptides and proteins.
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Loosening of Lipid Packing Promotes  
Oligoarginine Entry into Cells
The mechanisms for internalization of arginine-rich 
cell-penetrating peptides (CPPs), including the HIV-1 TAT 
peptide and oligoarginines, are still under debate although 
many factors that promote direct translocation of CPPs 
across the cell plasma membrane were reported (Figure 1A). 
These days, amphipathic helices are found in the common 
motif for membrane active peptides ⁄ proteins, including 
curvature inducing proteins. We previously reported that 
the N-terminal segment of epsin-1 possesses positive 
membrane curvature inducibility and that this peptide pro­
motes membrane translocation of R8, which is known as a 
representative CPP. We this time used differential scanning 
calorimetry (DSC) to assess the curvature inducibility of 
amphipathic peptides, which are derived from proteins to 
induce tabulation/fusion of liposomal membranes. As the 
result, cytosolic distribution of FITC-R8 was observed in 
the presence of EpN18 and Sar1p(1-23) with positive 
membrane curvature inducibility at about 80 % and 100 % 
of the cell population, respectively. Furthermore, the sites 
of R8 influx were found to have looser lipid packing than 
surrounding areas, revealed by using environment- sensitive 
probe (di-4-ANEPPDHQ). Taken together, the importance 
of lipid packing was demonstrated as a key factor, which 
underlies the various conditions to promote the direct 
membrane translocation of arginine-rich CPPs (Figure 1B).
Cytosolic Antibody Delivery  
by Lipid-sensitive Endosomolytic Peptide
Antibodies have high abilities in molecular recognition 
and targeting. Intracellular antibody delivery could thus 
achieve controlling cellular events, such as protein-protein 
interaction and post-translational modification. This sug­
gests the potential applicability of antibodies to attack in­
tracellular therapeutic targets. Many approaches for intra­
cellular delivery of biomacromolecules have been reported 
up to the present time. However, few of them are efficient 
enough to deliver high-molecular-weight proteins such as 
antibodies into cytosol to effectively modulate cell func­
tions.
In order to deliver various membrane-impermeable mol­
ecules into the cytosol effectively and efficiently, we devel­
oped a novel endosome-destabilizing peptide, L17E by 
engineering the structure of a hemolytic peptide derived 
from a spider toxin. This peptide showed significant stimu­
lation of cytosolic release of endocytosed molecules, in­
cluding polydextran (10kDa), Cre recombinase and anti­
bodies (IgG). Successful recognition of intracellular targets 
by the intracellularly delivered antibodies was confirmed 
by confocal microscopic analysis and the effect on signal 
transduction. These results suggested that this peptide 
holds the promise of modifying cell functions.
Unlike previously reported intracellular delivery pep­
tides and polymers, the mechanism of action of L17E was 
found to be its preferential perturbation of negatively 
charged endosomal membranes. Additionally, we found 
that L17E also has a property to stimulate cellular uptake 
amount of biomacromolecues. These are unique features 
equipped with our peptide which have not been reported 
for other delivery peptides and polymers. We serendipi­
tously found these features after we obtained this peptide.
Figure 1. The mechanism underlying the membrane penetration of R8.
Figure 2. A simple redesign of spider venom peptide ‘M-lycotoxin’ into 
L17E enables the efficient release of antibodies from their endosome cages.
